Based on this, we hypothesize that modulation of the myofibroblast response, by targeting signaling via PDGFRα, contributes to the beneficial effect seen on neurological and functional outcome with imatinib after ischemic stroke (9, 15). Here, PDGFRA is linked to ischemic stroke.